Literature DB >> 65182

Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.

R Einarsson, L O Andersson.   

Abstract

Corrected fluorescence excitation and emission spectra of human antithrombin III have been determined. The fluorescence observed originates almost entirely from tryptophan residues. Reduction of the disulfide bonds followed by carboxymethylation did not change the fluorometric properties of the protein. The binding of heparin to antithrombin III caused a marked fluorescence enhancement by about 30% of the intrinsic protein emission intensity. Various samples of heparin yielded different binding curves. Heparin fractionated by gel filtration seemed to be bound to two sites on antithrombin III with association constants of 0.6-10(6)m-1 and 0.2-10(6)M-1 respectively. Heparin, prepared by affinity chromatography on matrix-bound antithrombin III appeared to be bound to only one site with an association constant of 2.3-10(6)M-1. Under similar conditions heparin caused no increase of the intrinsic protein emission intensity when added to reduced and carboxymethylated antithrombin III. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65182     DOI: 10.1016/0005-2795(77)90110-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

Authors:  M F Scully; V Ellis; N Seno; V V Kakkar
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

2.  A fragment of antithrombin that binds both heparin and thrombin.

Authors:  L Rosenfeld; I Danishefsky
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  Re-formation of disulphide bonds in reduced antithrombin III.

Authors:  X J Sun; J Y Chang
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

4.  Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

5.  Interaction of heparin with synthetic antithrombin III peptide analogues.

Authors:  J Bae; U R Desai; A Pervin; E E Caldwell; J M Weiler; R J Linhardt
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

Review 6.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

7.  Binding to antithrombin of heparin fractions with different molecular weights.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

8.  Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.

Authors:  R Machovich; P I Bauer; P Arányi; E Kecskés; K G Büki; I Horváth
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

9.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

10.  Mechanism of inactivation of trypsin by antithrombin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.